Product Information

KETAMINE 500 MG/5 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.8061 per ML under NDC 00143950910. Its NADAC has been published 52 times since Nov 19, 2025.

FDA first approved this application on Mar 22, 1996. Its Orange Book therapeutic-equivalence code is AP.

KETAMINE 500 MG/5 ML VIAL

Ketamine Hydrochloride
$1.8061per ML
DEA Schedule CIII

Strength

100 mg/mL

NDC

00143950910

Classification

Generic

Dosage Form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

10/21/2026

Active Ingredients

KETAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074524

FDA Approved

3/22/1996

TE Code

AP

On Market Since

7/1/1996

Pharmacological Classes

General Anesthesia
General Anesthetic

Price Statistics

The NADAC for KETAMINE 500 MG/5 ML VIAL has been published 52 times since Nov 19, 2025, and over the history we have for it it has risen 15.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8061 per ML
All-time high$1.8061 (Nov 11, 2026)
All-time low$1.5436 (Jul 22, 2026)
52-week high$1.8061
52-week low$1.5436
Median price$1.5605
Average price$1.5931
Largest weekly change+15.3% (Sep 23, 2026)
Weeks tracked52
Tracking sinceNov 19, 2025

Price History

1W

0.0%

1M

+1.4%

3M

+17.0%

6M

+15.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

+15.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETAMINE 500 MG/5 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETAMINE 500 MG/5 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $1.8061 per ML (NDC 00143950910), effective Nov 11, 2026.

How has the price of KETAMINE 500 MG/5 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETAMINE 500 MG/5 ML VIAL has risen 15.6%. It has been tracked across 52 weekly CMS publications since Nov 19, 2025.

What are the highest and lowest recorded NADAC prices for KETAMINE 500 MG/5 ML VIAL?

Since Nov 19, 2025, the NADAC for KETAMINE 500 MG/5 ML VIAL has ranged from a low of $1.5436 (Jul 22, 2026) to a high of $1.8061 (Nov 11, 2026), with a median of $1.5605 per ML.

Are there cheaper alternatives to KETAMINE 500 MG/5 ML VIAL?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETAMINE 500 MG/5 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures KETAMINE 500 MG/5 ML VIAL?

KETAMINE 500 MG/5 ML VIAL (NDC 00143950910) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.